Insights Center
Thought leadership, news, events — you will find them all here, right at your fingertips. We’ve consolidated the firm’s most popular content in one, easy to search location. Enter a key word or phrase to find pertinent blog posts, articles, press releases, and upcoming events.
Mintz Direct
Mintz Viewpoints
Showing 10977 - 10984 of 12013 results
The (Best) Method to the Madness Behind Choosing a Company Name or Mark
July 22, 2013| Blog| Viewpoint
The Countdown Begins – Sunshine Act Data Collection
July 22, 2013| Blog| Viewpoint
BIA Reverses USCIS Denial of I-130 Petition for Same-Sex Couple in Matter of Zeleniak
July 21, 2013| Blog| Viewpoint
Proposed Medicare Cuts Would Significantly Impact Independent Laboratories
July 19, 2013| Blog| Viewpoint
Massachusetts Fair Share Law and HIRD Form Requirements Repealed
July 18, 2013| Alert| Viewpoint
First Year Analysis - The Pioneer ACO Program Wins Some, Loses Some
July 18, 2013| Blog| Viewpoint
Keeping Up With the Kardashians Is NOT a Defense Under HIPAA
July 18, 2013| Blog| Viewpoint
CPSC Approves $3.9 Million Penalty and Imposition of Compliance Program for National Retail Chain
July 17, 2013| Alert| Viewpoint
News & Press Releases
Mintz advised The Eagle Leasing Company, a leading provider of portable storage containers, ground level offices, semi-trailers, and mobile office solutions, in its acquisition by Rent-A-Container (RAC), a portfolio company of Kinderhook Industries, LLC.
Mintz’s Life Sciences practice has been shortlisted in multiple categories for the 2025 LMG Life Sciences Americas Awards. The winners will be announced at an awards ceremony in New York on September 4. In the United States, Mintz was shortlisted in the “Venture Capital Firm of the Year” category. In Canada, Mintz was shortlisted in the “Financial & Corporate Firm of the Year” and “Patent Strategy Firm of the Year” categories.
Mintz advised ArriVent BioPharma, Inc., a clinical-stage biopharmaceutical company dedicated to the identification, development, and commercialization of differentiated medicines to address the unmet medical needs of patients with cancers, on a $75 million underwritten public offering of 2,482,692 shares of its common stock and pre-funded warrants to purchase up to 1,363,469 shares of its common stock. The common stock is listed on The Nasdaq Global Market under the symbol “AVBP.“
Events
The Evolving Global Digital Infrastructure: Data Centers, AI, and the Next Wave of Connectivity
New York, NY
Mintz x The Engine: Supercharging Your IP Strategy with Trade Secrets
The Engine, 750 Main St. Cambridge, MA 02139
Podcasts
Health Law Diagnosed – Best Practices for Communicating with the FDA
July 9, 2025| Podcast|
Mintz On Air: Practical Policies – An Abridged Guide to Crisis Management
July 1, 2025| Podcast|